Contineum Therapeutics Inc
Contineum Therapeutics Inc (CTNM) Unusual Options Activity Today
CTNM options volume power reached 178x on the previous trading day. The highest reading was on the $20 CALL expiring 2026-12-18.
Read more
Checking CTNM unusual options activity helps you spot when traders are making outsized bets on Contineum Therapeutics Inc before the broader market catches on. Contineum Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor CTNM unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching CTNM unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking CTNM unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and CTNM unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. Its lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and progressive multiple sclerosis (MS). The company also develops PIPE-307, a novel, small molecule selective inhibitor of the muscarinic type 1 M1 receptor to treat depression and relapse remitting MS; and CTX-343, a peripherally-restricted LPA1R antagonist.
Contineum Therapeutics, Inc. was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. The company was incorporated in 2009 and is headquartered in San Diego, California.
Catalysts rarely arrive without a footprint, and CTNM unusual options activity is often where that footprint shows up first. Our scanner tracks Contineum Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at CTNM unusual options volume on the call side or chasing put sweeps, Contineum Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 15.00 | 0.25 | 1.30 | 0.78 | 137% | 1,500 | 21 | 7,142.86% |
| 2.50 | 8.00 | 12.60 | 10.30 | 408% | 0 | 0 | — |
| 5.00 | 5.50 | 10.10 | 7.80 | 238% | 0 | 0 | — |
| 7.50 | 3.00 | 7.70 | 5.35 | 163% | 0 | 0 | — |
| 10.00 | 1.00 | 5.20 | 3.10 | 130% | 0 | 0 | — |
| 2.50 | — | 3.80 | 3.80 | 1,000% | 0 | 0 | — |
| 5.00 | — | 0.05 | 0.05 | 230% | 0 | 0 | — |
| 7.50 | — | 0.05 | 0.05 | 139% | 0 | 55 | 0.00% |
| 10.00 | — | 0.80 | 0.80 | 189% | 0 | 202 | 0.00% |
| 12.50 | — | 2.00 | 2.00 | 193% | 0 | 2 | 0.00% |
As of September 28, 2026
Spot unusual options activity before it moves
Track CTNM options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→